Skip to main content

Table 1 Baseline characteristics of the included patients

From: Urokinase prophylactic anticoagulation in children with nephrotic syndrome: a multicenter retrospective cohort study

 

UK (N = 313)

Non-UK (N = 57)

P-value

Sex, Male (n, %)

211(66.7%)

35(61.4%)

0.38

Age (year)

5.7 ± 3.8

6.8 ± 4.4

0.06

Clinical pattern of NS (n, %)

  

0.01

 Steroid sensitive-infrequently relapsing

266(85.0)

40(70.2)

 

 Steroid sensitive-frequently relapsing

18(5.75)

7(12.3)

 

 Steroid sensitive-steroid dependent

16(5.11)

7(12.3)

 

 Steroid-resistant

13(4.15)

3(5.26)

 

Biopsy diagnosis (n, %)

  

0.61

 MCD

3(1)

1(1.8)

 

 mesangial hypercellularity

33(10.5)

4(9.8)

 

 MN

2(4.9)

0(0)

 

 FSGS

2(4.9)

1(1.8)

 

 MPGN

1(2.4)

0(0)

 

 no Biopsy

272(86.9)

51(89.5)

 

LMWH

0 (0)

3(1)

0.03

Median serum albumin(g/L)

Hypoproteinemia(n, %)

20.1 ± 5.1

272(86.9)

21.8 ± 5.9

44(77.2)

0.02

0.07

Fibrinogen(ug/L)

5.7 ± 1.4

6.1 ± 1.8

0.06

D-Dimer(ug/L)

1282.9 ± 1338.8

910.8 ± 1174.1

0.03

  1. The comparison between UK and Non-UK was made using T-test, Fischer’s test, or a Chi-squared test